Tokyo, Japan

Yukako Ishida

This inventor holds 1 USPTO granted patent. Top assignee: Kureha Chemical Industry Company, Limited. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yukako Ishida: Innovator in Pharmaceutical Composition

Introduction

Yukako Ishida is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on human proteins.

Latest Patents

Yukako Ishida holds a patent for the human ADAMTS-1 protein and its pharmaceutical composition. This patent describes a human ADAMTS-1 protein, a gene encoding the same, and a pharmaceutical composition containing the protein as an active ingredient. The invention also includes a method for immunologically analyzing the human ADAMTS-1 protein. Notably, the protein has the ability to decrease the number of leukocytes and platelets while simultaneously increasing the number of erythrocytes. She has 1 patent to her name.

Career Highlights

Yukako Ishida is associated with Kureha Chemical Industry Company, Limited, where she continues to advance her research and development efforts in the pharmaceutical sector. Her work has garnered attention for its potential applications in medical treatments.

Collaborations

Yukako has collaborated with notable colleagues, including Kunitaka Hirose and Kouji Matsushima, to further her research initiatives and enhance the impact of her inventions.

Conclusion

Yukako Ishida's contributions to the field of pharmaceuticals through her innovative patent on the human ADAMTS-1 protein highlight her role as a leading inventor. Her work not only showcases her expertise but also has the potential to influence future medical advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…